Legal & General Group
OPK icon

Legal & General Group’s Opko Health OPK Stock Holding History

Legal & General Group’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$520K Buy
346,787
+3,313
+1% +$4.22K ﹤0.01% 2388
2026
Q1 		$392K Sell
343,474
-109,791
-24% -$135K ﹤0.01% 2424
2025
Q4 		$571K Buy
453,265
+66,428
+17% +$92.4K ﹤0.01% 2384
2025
Q3 		$598K Buy
386,837
+31,155
+9% +$42.8K ﹤0.01% 2389
2025
Q2 		$469K Buy
355,682
+5,584
+2% +$7.63K ﹤0.01% 2462
2025
Q1 		$581K Sell
350,098
-20,340
-5% -$33.5K ﹤0.01% 2350
2024
Q4 		$545K Sell
370,438
-19,866
-5% -$30.4K ﹤0.01% 2428
2024
Q3 		$582K Sell
390,304
-22,798
-6% -$33.8K ﹤0.01% 2411
2024
Q2 		$516K Sell
413,102
-5,500
-1% -$7.13K ﹤0.01% 2413
2024
Q1 		$502K Hold
418,602
– – ﹤0.01% 2427
2023
Q4 		$632K Hold
418,602
– – ﹤0.01% 2365
2023
Q3 		$670K Sell
418,602
-4,209
-1% -$7.67K ﹤0.01% 2324
2023
Q2 		$918K Sell
422,811
-1,592
-0.4% -$2.49K ﹤0.01% 2260
2023
Q1 		$620K Buy
424,403
+25,428
+6% +$32.7K ﹤0.01% 2266
2022
Q4 		$499K Buy
398,975
+22,632
+6% +$35.7K ﹤0.01% 2340
2022
Q3 		$712K Buy
376,343
+29,143
+8% +$68.9K ﹤0.01% 2251
2022
Q2 		$878K Sell
347,200
-3,055
-0.9% -$8.91K ﹤0.01% 2205
2022
Q1 		$1.21M Buy
350,255
+6,716
+2% +$23.7K ﹤0.01% 2177
2021
Q4 		$1.65M Sell
343,539
-3,833
-1% -$15.5K ﹤0.01% 2095
2021
Q3 		$1.27M Buy
347,372
+90,502
+35% +$337K ﹤0.01% 2177
2021
Q2 		$1.04M Buy
256,870
+4,548
+2% +$17.8K ﹤0.01% 2205
2021
Q1 		$1.08M Buy
252,322
+7,610
+3% +$36.4K ﹤0.01% 2172
2020
Q4 		$966K Sell
244,712
-47,462
-16% -$198K ﹤0.01% 2125
2020
Q3 		$1.08M Buy
292,174
+23,883
+9% +$101K ﹤0.01% 2000
2020
Q2 		$915K Buy
268,291
+13,422
+5% +$30.1K ﹤0.01% 2008
2020
Q1 		$341K Sell
254,869
-15,549
-6% -$24.4K ﹤0.01% 2168
2019
Q4 		$397K Buy
270,418
+3,922
+1% +$6.57K ﹤0.01% 2265
2019
Q3 		$557K Buy
266,496
+136,666
+105% +$279K ﹤0.01% 2152
2019
Q2 		$316K Buy
129,830
+5,137
+4% +$11.2K ﹤0.01% 2235
2019
Q1 		$326K Buy
124,693
+4,864
+4% +$14.7K ﹤0.01% 2234
2018
Q4 		$361K Buy
119,829
+6,540
+6% +$22.2K ﹤0.01% 2188
2018
Q3 		$392K Hold
113,289
– – ﹤0.01% 2189
2018
Q2 		$532K Sell
113,289
-67,314
-37% -$255K ﹤0.01% 2091
2018
Q1 		$572K Sell
180,603
-28,909
-14% -$116K ﹤0.01% 2084
2017
Q4 		$1.03M Buy
209,512
+67,977
+48% +$394K ﹤0.01% 1875
2017
Q3 		$971K Buy
141,535
+21,017
+17% +$133K ﹤0.01% 1876
2017
Q2 		$793K Buy
120,518
+8,845
+8% +$62K ﹤0.01% 1912
2017
Q1 		$893K Buy
111,673
+76,487
+217% +$644K ﹤0.01% 1837
2016
Q4 		$327K Buy
35,186
+4,373
+14% +$45.2K ﹤0.01% 2091
2016
Q3 		$327K Buy
30,813
+4,945
+19% +$49.2K ﹤0.01% 1888
2016
Q2 		$242K Sell
25,868
-619
-2% -$6.29K ﹤0.01% 1701
2016
Q1 		$275K Buy
26,487
+7,234
+38% +$66.1K ﹤0.01% 1612
2015
Q4 		$193K Sell
19,253
-8,172
-30% -$81.9K ﹤0.01% 1760
2015
Q3 		$232K Buy
27,425
+10,853
+65% +$144K ﹤0.01% 1634
2015
Q2 		$265K Sell
16,572
-20,047
-55% -$312K ﹤0.01% 1605
2015
Q1 		$532K Buy
36,619
+7,243
+25% +$94.2K ﹤0.01% 1272
2014
Q4 		$294K Sell
29,376
-722
-2% -$6.18K ﹤0.01% 1392
2014
Q3 		$259K Buy
+30,098
New +$265K ﹤0.01% 1384

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legal & General Group's OPK Position: Q2 2026 in Review

Legal & General Group increased its Opko Health (OPK) stake by 0.96% in Q2 2026, buying an estimated $4.22K and bringing the position to 346,787 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Legal & General Group first reported a position in OPK in Q3 2014 and has held it in 48 quarters since. The position peaked at $1.65M in Q4 2021. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Legal & General Group held 346,787 shares of Opko Health worth $520K as of Q2 2026.
  • Legal & General Group bought 3,313 Opko Health shares in Q2 2026, an estimated $4.22K.
  • Opko Health made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2388 holding.
  • Legal & General Group first reported a position in Opko Health in Q3 2014 and has held it in 48 quarters since.
  • Legal & General Group's Opko Health position peaked at $1.65M in Q4 2021.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.